Want to join the conversation?
$REGN 2Q15 PR: Total revenues, which include product revenues, increased by 50% to $999MM compared to $666MM in 2Q14. GAAP net income was $195MM or $1.89 per basic share and $1.69 per diluted share compared to GAAP net income of $96MM or $0.96 per basic share and $0.85 per diluted share in 2Q14.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?